TNF and neoplasm: Among the Th1 cytokines (Fig. 3C), tumor necrosis factor (TNF), a critical cytokine that is required for an anti-tumor immune response, was induced at significantly higher levels by toripalimab (1.85-fold) than pembrolizumab (1.42-fold).